
FOLLOWUS
1.Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing (100700), China
2.Department of Andrology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing (100091), China
3.Department of Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu (610072), China
4.The Second Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu(611137), China
5.Graduate School of China Academy of Chinese Medical Sciences, Beijing (100700), China
6.Department of Nephropathy, Qian'an Traditional Chinese Medicine Hospital, Tangshan, Hebei Province (064404), China
7.Graduate School of Hebei University of Chinese Medicine, Shijiazhuang (050091), China
Prof. ZHAO Jia-you, E-mail: zhaojiayou520@126.com
录用:2025-06-06,
网络首发:2025-09-12,
纸质出版:2026-02
Scan QR Code
ZOU He-de, ZHANG Pei-hai, CHEN Wen-kang, 等. 化湿通痹方治疗湿热蕴脾型勃起功能障碍的多中心、随机、对照、非劣效性试验[J]. Chinese Journal of Integrative Medicine, 2026,32(2):111-119.
ZOU He-de, ZHANG Pei-hai, CHEN Wen-kang, et al. Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 111-119.
ZOU He-de, ZHANG Pei-hai, CHEN Wen-kang, 等. 化湿通痹方治疗湿热蕴脾型勃起功能障碍的多中心、随机、对照、非劣效性试验[J]. Chinese Journal of Integrative Medicine, 2026,32(2):111-119. DOI: 10.1007/s11655-025-4142-0.
ZOU He-de, ZHANG Pei-hai, CHEN Wen-kang, et al. Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 111-119. DOI: 10.1007/s11655-025-4142-0.
目的:
2
评价中药复方化湿通痹方(Huashi Tongbi Formula
HTF)治疗湿热蕴脾型勃起功能障碍(erectile dysfunction
ED)的疗效和安全性
并基于肠道菌群分析探讨其可能的作用机制.
方法:
2
采用多中心、随机、平行阳性对照、非劣效性试验方法
纳入162例湿热蕴脾型ED患者
使用随机数字表法按2:1比例随机分为治疗组(108例)和对照组(54例). 治疗组给予HTF颗粒(每次1袋
每日2次). 对照组给予枸橼酸西登那片(50mg
按需口服). 两组均治疗8周
随访8周. 主要指标为治疗8周后的有效率
采用意向治疗(intention-to-treat
ITT)和符合方案(per-protocol
PP)方法进行分析
次要指标包括国际勃起功能指数-5(International Index of Erectile Function-5
IIEF-5)评分、勃起质量评分(Erectile Quality Score
EQS)、和中医证候 (Chinese medicine syndrome
CMS) 评分
在8周的治疗期内每2周进行ITT分析
在8周随访期内每4周进行ITT分析. 16S rDNA测序用于分析HTF对肠道微生物群的影响. 记录两组患者的不良事件(adverse events
AEs)和安全性指标变化情况.
结果:
2
共有162例患者纳入ITT分析
其中23例患者在试验期间退出(治疗组12例
对照组11例)
139例患者纳入PP分析. ITT和PP分析显示
治疗8周后
治疗组和对照组有效率的差异和95%置信区间(confidence intervals
CIs)分别为-3.7%(-17.9%
10.5%) 和-4.5%(-18.2%
9.2%). 治疗2周时
治疗组IIEF-5和EQS评分较低
CMS评分较高(
P
<
0.05); 治疗4周时
治疗组IIEF-5较低 (
P
<
0.05)
两组EQS和CMS评分相当(
P
>
0.05); 治疗6周时
两组所有评分 (IIEF-5、EQS、CMS)组间相当(
P
>
0.05); 治疗8周时
两组IIEF-5和EQS评分相当
治疗组CMS评分较低(
P
<
0.05). 在第4周和第8周随访中
治疗组IIEF-5和EQS评分较高
CMS评分较低(
P
<
0.05). 与基线相比
治疗后两组显示所有评分均改善(
P
<
0.05). 两组安全性指标差异无统计学意义(
P
>
0.05). HTF治疗后
毛螺菌科和布劳特氏菌属相对丰度增加
对组间微生物群落的差异贡献最大. 治疗组短乳杆菌和乳植杆菌丰度增加
嗜胆菌属、糖单胞菌、髌骨菌和其他细菌丰度减少(线性判别分析
>
2). 治疗组氨基酸相关酶、外
泌体、线粒体生物发生等肠道微生物群的9种预测功能降低
蛋白激酶功能增加(
P
<
0.05).
结论:
2
HTF治疗湿热蕴脾型ED的疗效不劣于西地那非片
具有缓解整体症状和停药后疗效稳定持久的优势
其机制可能由调节肠道菌群介导. (注册号: ChiCTR2300067825)
Objective:
2
To evaluate the effect and safety of Chinese herbal compound Huashi Tongbi Formula(HTF) for the treatment of erectile dysfunction (ED) with damp heat affecting Pi (Spleen) pattern
and explore the possible mechanisms based on the analysis of gut microbiota.
Methods:
2
In this multicentre
randomized
parallel
positive control
noninferiority trial
a total of 162 ED patients with damp heat affecting Pi pattern were randomly divided into a treatment group (108 patients) and a control group (54 patients) in a 2:1 ratio using a random number table method. The treatment group was administered HTF granules (1 bag each time
twice a day). The control group was given sildenafil citrate tablets (50 mg
orally as needed). Both groups were treated for 8 weeks with a 8-week followed-up period. The main indicator was effective rate after 8-week treatment analysed using intention-to-treat (ITT) and per-protocol (PP) methods
and the secondary indicators included International Index of Erectile Function-5 (IIEF-5) score
Erectile Quality Score (EQS)
and Chinese medicine syndrome (CMS) score
which were analysed using ITT every 2 weeks during 8-week treatment period
and every 4 weeks during 8-week follow-up period. The 16S rDNA sequencing was used to analyse the impact of HTF on the gut microbiota. The adverse events (AEs) and changes in safety indicators of the two groups were recorded.
Results:
2
A total of 162 patients were included in the ITT analysis
with 23 patients dropping out during the trial period (12 in the treatment group and 11 in the control group)
and 139 patients were included in the PP analysis. ITT and PP analyses revealed that after 8-week treatment the difference and 95% confidence intervals (CIs) in the effective rates between the treatment and the control groups were –3.7% (–17.9%
10.5%) and –4.5% (–18.2%
9.2%)
respectively. At 2 weeks of treatment
the treatment group showed lower IIEF-5 and EQS scores but higher CMS score
vs
. control (
P
<
0.05); at 4 weeks
IIEF-5 remained lower (
P
<
0.05)
while EQS and CMS scores were comparable (
P
>
0.05); by 6 weeks
all scores (IIEF-5
EQS
CMS) were similar between groups (
P
>
0.05); at 8 weeks
IIEF-5 and EQS were comparable
but CMS scores were lower (
P
<
0.05). During 4- and 8-week follow-up
the treatment group had higher IIEF-5 and EQS scores and lower CMS scores (
P
<
0.05). Both groups showed significant improvements in all scores from baseline (
P
<
0.05). There was no significant difference in the safety indicators between groups (
P
>
0.05). After HTF treatment
the relative abundances of
Lachnospiraceae
and
Blautia
increased
contributing the most to the differences in the microbial communities between groups. The abundances of
Levilactobacillus
and
Lactiplantibacillus
increased
whereas the abundances of
Bilophila
Saccharimonadia
Patescibacteria
and others decreased in the treatment group (linear discriminant analysis score
>
2). Nine predictive functio
ns of the gut microbiota including amino acid related enzymes
exosome
mitochondrial biogenesis
etc. were reduced
whereas protein kinase function increased in the treatment group(
P
<
0.05).
Conclusion:
2
HTF showed noninferior efficacy to sildenafil for ED with damp heat affecting Pi pattern
with the advantages of relieving overall symptoms and stable and lasting therapeutic effect after discontinuation
potentially mediated by gut microbiota modulation. (Registration No. ChiCTR2300067825)
0
浏览量
3
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621